ATRC ATRICURE
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 15 analyst firms say about ATRICURE: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
14 rated views · 17 analyst/firm records · 15 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8028
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8055
Recent analyst activity · last 90 days
Our tracked history has 17 reports on ATRC from 13 analyst firms in the last 90 days (15 firms in the past year).
Comparing each firm's latest target with its previous one: 5 raised their price target and 3 have their first observed target in the past year.
Ratings, latest available report against the previous one: 0 upgrades and 1 downgrade.
Latest observed target change: BTIG Research raised its target from $63.00 (set 12 Oct 2026) to $70.00 on 4 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| BTIG | Marie Thibault | Buy | 24 Aug 2026 | Conflicting reports · excluded |
| BTIG | Ryan Zimmerman | Buy | 12 Oct 2026 | 63.00 USD |
| Canaccord Genuity | William Plovanic | Buy | 6 May 2026 | 55.00 USD |
| Citigroup | Unnamed analyst | Buy | 21 Oct 2026 | — |
| Citizens JMP | Daniel Stauder | Buy | 21 Oct 2026 | 68.00 USD |
| Citizens JMP | David L Turkaly | Buy | 21 Oct 2026 | 68.00 USD |
| Freedom Capital | Unnamed analyst | Hold | 2 Oct 2026 | — |
| Freedom Capital Markets | Keith Hinton | Hold | 2 Oct 2026 | 57.00 USD |
| JPMorgan | Lilia-Celine Lozada | Hold | 11 Feb 2026 | 36.00 USD |
| Needham | Mike Matson | Buy | 2 Sep 2026 | Conflicting reports · excluded |
| Oppenheimer | Suraj Kalia | Hold | 18 Feb 2026 | — |
| Piper Sandler | Matt O'Brien | Buy | 27 Aug 2026 | Conflicting reports · excluded |
| Raymond James | Unnamed analyst | — | 21 Jul 2026 | 52.00 USD |
| Stifel | John McAulay | — | 17 Sep 2026 | 65.00 USD |
| UBS | Priya Sachdeva | Sell | 21 Oct 2026 | — |
| Weiss Ratings | Unnamed analyst | — | 8 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 24 Aug 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:49 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.